开云网页登录_开云app官网入口下载苹果版

Abstract

CLC Number:

R446.11

Figures/Tables1

References40

[1]	Patel K, Fasanya A, Yadam S, et al. Pathogenesis and Epidemiology of Venous Thromboembolic Disease[J]. Crit Care Nurs Q, 2017, 40(3):191-200.
[2]	Heit JA. Thrombophilia: common questions on laboratory assessment and management[J]. Hematology Am Soc Hematol Educ Program, 2007:127-135.
[3]	Law Y, Chan YC, Cheng SWK. Epidemiological updates of venous thromboembolism in a Chinese population[J]. Asian J Surg, 2018, 41(2):176-182.
[4]	杨媛华. 提高我国肺血栓栓塞症诊疗水平的系列研究——2008年度国家科学技术进步二等奖[J]. 首都医科大学学报, 2009, 30(1):5-7.
[5]	Angchaisuksiri P. Venous thromboembolism in Asia--an unrecognised and under-treated problem?[J]. Thromb Haemost, 2011, 106(4):585-590.
[6]	Ding Q, Wang M, Xu G, et al. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients[J]. Thromb Res, 2013, 132(3):367-373.
[7]	Ding Q, Shen W, Ye X, et al. Clinical and genetic features of protein C deficiency in 23 unrelated Chinese patients[J]. Blood Cells Mol Dis, 2013, 50(1):53-58.
[8]	Li L, Wu X, Wu W, et al. Clinical Manifestation and Mutation Spectrum of 53 Unrelated Pedigrees with Protein S Deficiency in China[J]. Thromb Haemost, 2019, 119(3):449-460.
[9]	Lee EJ, Dykas DJ, Leavitt AD, et al. Whole-exome sequencing in evaluation of patients with venous thromboembolism[J]. Blood Adv, 2017, 1(16):1224-1237.
[10]	Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, et al. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex[J]. Proc Natl Acad Sci U S A, 1996, 93(19):10212-10216.
[11]	Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease[J]. J Clin Invest, 1981, 68(5):1370-1373.
[12]	Schwarz HP, Fischer M, Hopmeier P, et al. Plasma protein S deficiency in familial thrombotic disease[J]. Blood, 1984, 64(6):1297-1300.
[13]	Tang L, Wang HF, Lu X, et al. Common genetic risk factors for venous thrombosis in the Chinese population[J]. Am J Hum Genet, 2013, 92(2):177-187.
[14]	Saposnik B, Reny JL, Gaussem P, et al. A haplotype of the EPCR gene is associated with increased plasma leve-ls of sEPCR and is a candidate risk factor for thrombosis[J]. Blood, 2004, 103(4):1311-1318.
[15]	Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C[J]. Nature, 1994, 369(6475):64-67.
[16]	Buchanan GS, Rodgers GM, Ware Branch D. The inheri-ted thrombophilias: genetics, epidemiology, and laboratory evaluation[J]. Best Pract Res Clin Obstet Gynaecol, 2003, 17(3):397-411.
[17]	Egeberg O. Inherited antithrombin deficiency causing thrombophilia[J]. Thromb Diath Haemorrh, 1965, 13:516-530.
[18]	Bernardi F, Legnani C, Micheletti F, et al. A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects[J]. Thromb Haemost, 1996, 76(4):505-509.
[19]	Dziadosz M1, Baxi LV. Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review[J]. Blood Coagul Fibrinolysis, 2016, 27(5):481-489.
[20]	Takagi Y, Murata M, Kozuka T, et al. Missense mutations in the gene encoding prothrombin corresponding to Arg596 cause antithrombin resistance and thrombomo-dulin resistance[J]. Thromb Haemost, 2016, 116(6):1022-1031.
[21]	Segers O, Simioni P, Tormene D, et al. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes[J]. J Thromb Haemost, 2012, 10(1):73-80.
[22]	Mannucci PM, Franchini M. Classic thrombophilic gene variants[J]. Thromb Haemost, 2015, 114(5):885-889.
[23]	Steen M, Norstrom EA, Tholander AL, et al. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis[J]. Blood, 2004, 103(9):3381-3387.
[24]	Castoldi E. FⅤ and APC resistance: the plot thickens[J]. Blood, 2014, 123(15):2288-2889.
[25]	Simioni P1, Tormene D, Tognin G, et al. X-linked thrombophilia with a mutant factor IX (factor IX Padua)[J]. N Engl J Med, 2009, 361(17):1671-1675.
[26]	Ichinose A, Espling ES, Takamatsu J, et al. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis[J]. Proc Natl Acad Sci U S A, 1991, 88(1):115-119.
[27]	Shigekiyo T, Yoshida H, Matsumoto K, et al. HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein(HRG) deficiency[J]. Blood, 1998, 91(1):128-133.
[28]	Moatti D, Haidar B, Fumeron F, et al. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels[J]. Thromb Haemost, 2000, 84(2):244-249.
[29]	Connors JM. Thrombophilia Testing and Venous Thrombosis[J]. N Engl J Med, 2017, 377(23):2298.
[30]	中华医学会血液学分会血栓与止血学组. 易栓症诊断中国专家共识(2012年版)[J]. 中华血液学杂志, 2012, 33(11):982.
[31]	包承鑫. 遗传性易栓症的诊断[J]. 诊断学理论与实践, 2006, 5(5):452-454.
[32]	《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36):2861-2888.
[33]	王鸿利, 王学锋. 遗传性易栓症的规范化诊断[C]. 华东地区血液学学术会议暨江苏省第十三次血液学学术会议, 2009.
[34]	Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism[J]. J Thromb Haemost, 2013, 11(3):412-422.
[35]	Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J]. J Thromb Haemost, 2006, 4(2):295-306.
[36]	Keeling D, Mackie I, Moore GW, et al. Guidelines on the investigation and management of antiphospholipid syndrome[J]. Br J Haematol, 2012, 157(1):47-58.
[37]	Ding Q, Yang L, Dinarvand P, et al. Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays[J]. Blood, 2015, 125(15):2428-2434.
[38]	Yin T, Takeshita S, Sato Y, et al. A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency[J]. Thromb Haemost, 2007, 98(4):783-789.
[39]	Choung HS, Kim HJ, Gwak GY, et al. Inherited protein S deficiency as a result of a large duplication mutation of the PROS1 gene detected by multiplex ligation-dependent probe amplification[J]. J Thromb Haemost, 2008, 6(8):1430-1432.
[40]	Zhang X, Xu Y, Liu D, et al. A modified multiplex ligation-dependent probe amplification method for the detection of 22q11.2 copy number variations in patients with congenital heart disease[J]. BMC genomics, 2015, 16:364.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables1

References40

Related Articles7

Recommended Articles

Metrics

Comments

[1]	ZHOU Lu, LEI Hang, HONG Ye, JIN Shuang, DONG Yongqin, WANG Xuefeng, CAI Xiaohong.A_wB subtype caused by a novelABO *Aallele and its molecular mechanisms[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 547-551.
[2]	LEI Hang, FAN Liangfeng, CAI Xiaohong, WANG Yuqing, LIU Xi, JIN Sha, SHEN Wei, LU Qiong, XIANG Dong, WANG Xuefeng, ZOU Wei.The study on molecular basis of ABO blood subgroups in the Chinese population[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 364-369.
[3]	GONG Ruhan, LI Jia, HUANG Kaifeng.Establishment of fluorescence PCR method using blood specimens for a rapid genetyping and its application inADRB1genotyping[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 402-406.
[4]	ZHU Chao, GUAN Jialiang, LI Zhe, LIU Yu, WANG Xuefeng, WU Wenman.Research on correlation between results of dilutedRussellviper venom time (dRVVT) test and mixing test in detection of lupus anticoagulant[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 28-31.
[5]	LI Lei, WU Xi, XU Guanqun, LIANG Qian, DAI Jing, WU Wenman, DING Qiulan, WANG Hongli, WANG Xuefeng.Establishment and application of thrombophilia gene detection panel based on next generation sequencing in identification of genetic background of Chinese patients with venous thromboembolism[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(04): 394-401.
[6]	WANG Dengfeng, CUI Wenyan, ZOU Wei, LI Fang, WANG Xuefeng, CAI Xiaohong.Molecular mechanism of A_xsubtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 260-265.
[7]	.[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(04): 358-362.